Triomics is a software company that enables cancer centers to leverage their health record data with Generative AI, aiming to reduce the manual workload involved in oncology research and care. Triomics focuses on transforming how oncology data is accessed and utilized, helping healthcare institutions streamline processes that traditionally require significant manual effort.
Their platform applies advanced AI technologies to extract, organize, and make sense of electronic health records within oncology, supporting more efficient research workflows and care delivery. By automating data-intensive tasks, Triomics addresses a major pain point for cancer centers—freeing up clinical and research staff to focus on higher-value activities while improving data accuracy and usability.
How was Triomics started?
Triomics was founded by a multidisciplinary team with expertise spanning AI, clinical data, engineering, security, and healthcare operations. Key founding members include Sarim Khan (Co-Founder and CEO), Hrituraj Singh (Co-Founder and CTO), and experts such as Regina Schwind (Clinical Data), Daniel Novinson (Medical Director), Mauro Nievas (AI/ML), and others. This diverse leadership team brings together backgrounds in technology, medicine, and compliance, reflecting the company’s focus on bridging technical innovation with real-world clinical needs. Learn more about their team and mission.
Who uses Triomics?
Triomics primarily serves cancer centers and healthcare institutions engaged in oncology research and care. Their solutions are designed for organizations seeking to make better use of their existing health record data, especially where large-scale manual data processing previously limited efficiency or scale. While specific customer names have not been disclosed, Triomics' platform is geared toward medical research organizations, hospitals, and cancer treatment centers looking to modernize their data workflows.
What makes Triomics different?
Unlike traditional data management systems, Triomics leverages Generative AI specifically for oncology use cases, allowing for more nuanced data extraction and workflow automation. This specialization in oncology and focus on reducing manual data handling distinguishes Triomics from broader healthcare data software providers.
Where is Triomics based and how big is the company?
Triomics is headquartered in San Francisco, California, United States, and operates as a privately held company with a team size between 51 and 200 employees.
Use PromptLoop to Uncover Company Data
Looking for more company insights like this? PromptLoop helps you go deeper, providing unique data points and analysis on companies like Triomics and many others. Automate your research and find the information that matters most. Discover how PromptLoop can accelerate your market intelligence. Get A Free Demo to learn more.